From the JAMA Network: Incidence and Nat...

Dalbavancin, a long-acting IV lipoglycopeptide, may be an option for the treatment of complicated Staphylococcus aureus bacteremia without requiring long-term IV access. Author Thomas L. Holland, MD, MSc, from Duke University School of Medicine discusses key points of the DOTS ra ... Show More

Interview with Dennis J. Rivet II, MD, author of GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension. Hosted by Cynthia E. Armand, MD. Related Content: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension 

Nationwide data are unavailable regarding changes in intensive care unit (ICU) outcomes over the past 10 years, limiting understanding of practice changes. Authors Emily Moin, MD, MBE, and Scott D. Halpern, MD, PhD, MBE, of the University of Pennsylvania join JAMA Associate Edito ... Show More

For a probing discussion detailing the American Lung Association’s recent 2024 “State of Lung Cancer” report, we are joined by esteemed thoracic medical oncologist Dr. Jacob Sands of Dana-Farber Cancer Institute and Harvard Medical School. Offering insight into actionable targete ... Show More

Ninja Nerds,Welcome to the Ninja Nerd Podcast with Zach and Rob! In this episode, we discuss Lung Cancer, a leading cause of cancer-related mortality worldwide. We explore the pathophysiology, risk factors, and key differences between non-small cell lung cancer (NSCLC) and small ... Show More

Our guest is Dr. Kyle Richards, a urologic oncologist and Associate Professor in the Department of Urology at the University of Wisconsin. He talks with us about the basics around non-muscle invasive bladder cancer. Learn about common symptoms, diagnosis and treatment options to ... Show More

The incidence of early onset colorectal cancer (EOCRC) has been rising prompting the change in change in screening guidelines to 45 years of age for average risk patients. Join us for an in-depth discussion with guest speakers Dr. Andrea Cercek and Dr. Nancy You, where we provide ... Show More

In this first episode of a two-part series on surgical oncology, host Rick Greene, MD, FACS, is joined by Drs. John Stewart and Prakash Pendalai to discuss the genetic and molecular features of cancer. They also discuss screening methods and other preventive interventions, with a ... Show More

In this special edition of Lung Cancer Considered, three oncologists and lung cancer experts explore lung cancer in the Middle East (North Africa), spoken in Arabic. Host Dr. Nagla Karim, MD, PHD, Director of the Phase I Program at the Inova Schar Cancer Institute welcomes guests ... Show More

Joël Guigay discusses the ELAN-FIT and ELAN-UNFIT trials in older people with head and neck cancer, published in The Lancet Healthy Longevity, and the importance of geriatric assessments in clinical trials of older cancer patients.Read the full articles:https://www.thelancet.com/ ... Show More

0:16 Intro 2:28 Recent modifications to the lung allocation score 5:11 Monitoring chronic graft rejection 9:23 The rising use of ex vivo lung perfusion  16:17 The presence of post-COVID patients on the lung transplant waitlist 21:01 Impact of long Covid on transplant rehabilitati ... Show More

What does it take to improve quality of life after head and neck cancer? In this episode of Backtable ENT, guests Dr. Heather Starmer, a speech and language pathologist at Stanford University, and Dr. Michael Moore, a head and neck cancer surgeon at Indiana University explore the ... Show More

Today I am speaking with Dr. Leigh Erin Connealy, MD. Dr. Connealy is absolutely amazing, and I was so interested to have her on the podcast because of her incredible experience and philosophy on cancer prevention. We discuss cancer rates, what she recommends for preventing cance ... Show More